Please see US Full Prescribing Information forOPDIVOandYERVOY. Clinical Trials and Patient Populations Checkmate 227–previously untreated metastatic non-small cell lung cancer, in combination with YERVOY; Checkmate 9LA–previously untreated recurrent or metastatic non-small cell lung cancer in combination...
3. Opdivo. Prescribing information. Bristol-Myers Squibb; 2024. Accessed September 15, 2024. 4. Hodi FS, Chiarion-Sileni V, Lewis KD, et al. Long-term survival in advanced melanoma for patients treated with nivolumab plus ipilimumab inCheckMate067. J Clin Oncol. 2022;40(suppl 16):9522-952...
[2] Prescribing Information- Nivolumab. Retrieved September 15, 2022 from网页链接 @药明康德内容团队报道 免责声明:药明康德内容团队专注介绍全球生物医药健康研究进展。本文仅作信息交流之目的,文中观点不代表药明康德立场,亦不代表药明康德支持或反对文中观点。本文也不是治疗方案推荐。如需获得治疗方案指导,请前往正规...
1. Bristol-Myers Squibb. Opdualag (nivolumab/relatlimab) for injection prescribing information. Princeton, NJ; 2022 Mar. 2. US Food and Drug Administration. Search orphan drug designations and approvals. From FDA website. Accessed 2023 November 22. https://www.accessdata.fda.gov/scripts/opd...
The recommended dosages of OPDIVO in combination with other therapeutic agents are presented in Table 2. Refer to the respective Prescribing Information for each therapeutic agent administered in combination with OPDIVO for the recommended dosage information, as appropriate. ...
OpdivoPrescribing Information.OpdivoU.S. Product Information. Last Updated: March 2022. Princeton, NJ: Bristol-Myers Squibb Company. Uramoto H, Tanaka F. Recurrence after surgery in patients with NSCLC.Translational Lun...
Opdivo Prescribing Information. Opdivo U.S. Product Information. Last updated: January 23, 2016. Princeton, NJ: Bristol-Myers Squibb Company. Larkin J, Chiarion-Sileni V, Gonzalez R, et al. Combined nivolumab and ipilimumab or monotherapy in untreated melanoma. N Engl J Me...
Prescribing Information (Bristol Myers Squibb, 2021). Das, R. et al. Combination therapy with anti-CTLA-4 and anti-PD-1 leads to distinct immunologic changes in vivo. J. Immunol. 194, 950–959 (2015). Article CAS Google Scholar Brahmer, J. R. et al. Phase I study of single-agent...
OpdivoPrescribing Information.OpdivoU.S.Product Information. Last updated:October 2024.Princeton, NJ:Bristol-Myers Squibb Company. Cascone T, Awad M, Spicer J, et al. Perioperative Nivolumab in Resectable Lung Cancer.N Engl J Med. 2024;390:1756-1769. ...
Please see U.S. Full Prescribing Information forOPDIVOandYERVOY.